[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/pages/docs/Technology/index.md) >> Individual ID:PBN__Technology_8133 

# __Clinical trial platforms__

## Risks linked to this technology

* [Repurposing existing drugs without sufficient evidence for effectiveness against covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6684.md)
* [Use of ai in drug discovery for contagious diseases without thorough validation and testing](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6685.md)

## This Technology belongs to this TechGroup

* [Healthcare](https://github.com/mm80843/T3.5/blob/pages/TechGroup/PBN__TechGroup_2.md)

## This Technology belongs to this TechSubgroup

* [Vaccination development and distribution](https://github.com/mm80843/T3.5/blob/pages/TechSubgroup/PBN__TechSubgroup_66.md)

## This technology is mentioned by

* [Chamola_comprehensive_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_430.md)

